Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094014 · ClinicalTrials.gov registry record
Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 46
- Enrollment target
NCT02094014 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 46 participants.
The verdict
NCT02094014 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive response, enabling future work to develop auditory masking as a treatment adjuvant targeting long-term improvement in speech. Providing an additional treatment option for adults with aphasia and apraxia of speech will have the clear benefit of improving quality of life and allowing individuals to participate more actively in their health care decisions through improved communication.
Interventions
- BEHAVIORAL Normal Auditory Feedback
- BEHAVIORAL Masked Auditory Feedback
- BEHAVIORAL Altered Auditory Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02094014
The ClinicalTrials.gov registry entry for NCT02094014 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Normal Auditory Feedback is the first listed.
NCT02094014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02094014 about?
NCT02094014 is a clinical study titled "Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech". Impaired speech production is a major obstacle to full participation in life roles by stroke survivors with aphasia and apraxia of speech. The proposed study will demonstrate the short-term effects of auditory masking on speech disfluencies and identify individual factors that predict a positive res...
What is the current status of trial NCT02094014?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2014-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02094014?
The interventions under investigation include: Normal Auditory Feedback (BEHAVIORAL), Masked Auditory Feedback (BEHAVIORAL), Altered Auditory Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02094014?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.